Latest filing published 11 Mar 2025 for Thermo Fisher Scientific INC., €1.9M.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Michael A. Boxer, SVP and General Counsel of Thermo Fisher Scientific Inc., filed 70 disclosures between January 3, 2018 and March 11, 2025. None falls in the last twelve months. Market trades are rare but heavy: 6 sales worth EUR 16.9 million, median EUR 1,479,325, including EUR 7,609,873 on February 7, 2024, EUR 4,219,408 on August 8, 2022 and EUR 1,851,223 on March 10, 2025.
One purchase, EUR 1,929, took place on June 26, 2023; it makes up 14% of market trades but is a tiny amount next to the sales. Most of the record is 56 grants, with 5 option exercises and 2 other filings.
The yearly volume rises from 4 filings in 2018 to 16 in 2024, after 10 in 2021 and 11 in 2022 and in 2023. The median publication delay is 2 days.
At Thermo Fisher, 6 of Michael A. Boxer's own market trades fall within 30 days of trades by Marc N. Casper, in the same direction, and 2 within 30 days of each of Gianluca Pettiti and Stephen Williamson. With Nelson Chai, 2 are close, 1 of them in the same direction.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 70 declarations